We focus on end-to-end technical services covering full CAR-T development workflow: precise CAR-T monitoring reagents, proprietary anti-idiotype antibody platforms, and customized VHH nanobody development for novel cell therapy projects.
We welcome attending academic investigators, clinical physicians and biotech industry partners to drop by our booth for technical consultation and project cooperation discussion. Pre-meeting one-on-one appointment is available via prior email contact.